The Rise of a New Era

February 10, 2010

The cool evening breeze drifted through the open windows of Krishna Deva Raya's private study in the Vellore Royal Palace. The soft glow of candlelight flickered against the ornate wooden panels, creating a serene yet commanding atmosphere.

Krishna sat at his desk, reviewing the final documents for the registration of Oasis Mining and Oasis Battery Company. The system had made the necessary arrangements, and now both companies officially existed within the financial and industrial ecosystem of Vijayanagara.

He leaned back, fingers tapping the armrest of his leather chair. He had given 30% ownership of both companies to the Royal Investment Bureau, ensuring that the wealth generated would directly benefit the Vijayanagara Royal Family.

The Royal Investment Bureau was no ordinary institution. Modeled after financial titans like BlackRock, Sequoia Capital, and Vanguard Inc., it had investments across multiple industries, from technology and infrastructure to real estate and pharmaceuticals. By strengthening its stake in emerging industries, Krishna was setting the stage for the royal family to hold unparalleled economic power in the future.

A small smile played on his lips. "This is only the beginning."

February 12, 2010

The palace halls buzzed with an air of excitement. Priya, Krishna's loyal secretary, entered his study with hurried steps, her eyes gleaming with barely contained enthusiasm.

"Your Highness, the box office numbers for Ramayana: The Legend of Ram are in!" she announced breathlessly.

Krishna looked up from his papers, his curiosity piqued. "And?"

She handed him a detailed financial report. "The global box office has reached 970 million US dollars."

For a moment, there was silence. Krishna took a slow breath as he scanned the figures.

"According to President Venkatesh," Priya continued, "Dream Chaser Studios will receive 357 million dollars in revenue. Even with a rumored production budget of 250 million dollars, the net profit should easily surpass 100 million."

Krishna frowned slightly. "970 million… it didn't break 1 billion?"

Priya hesitated. "No, Your Highness."

His fingers tapped rhythmically against the wooden desk. He had expected more. The film had been made with cutting-edge animation, superior to anything Hollywood had produced—even by the standards of 15 years into the future.

And yet…

It had fallen short.

"It's the cultural gap," Krishna mused aloud. "Western audiences have yet to fully embrace Eastern epics. No matter how advanced the visuals are, the unfamiliarity of our mythology limits its reach."

Priya nodded in agreement. "Still, this is an incredible achievement. An Indian animated film has nearly hit a billion-dollar box office worldwide."

Krishna sighed, then allowed himself a small smile. "You're right. This is only our first step. There will be more films, and in time, the world will embrace our stories."

Just as Priya was about to leave, she turned back with another report in hand.

"One more thing, Your Highness. President Venkatesh has finalized the agreement with Universal Pictures."

Krishna raised an eyebrow. "Oh? Tell me more."

"Universal has agreed to license the Jurassic Park IP to Dream Chaser Films for the development of a theme park. Additionally, the two companies will collaborate on three new films under the Jurassic Park franchise."

Krishna was genuinely surprised. "Universal actually agreed to this?"

Priya nodded. **"Yes, Your Highness. Under the terms of the agreement:

• The total budget for the three films is 1 billion dollars.

• Universal will invest only 300 million dollars, while Dream Chaser will cover the remaining 700 million.

• The box office revenue will be shared 55%-50% in favor of Universal.

• The copyright of the film and animation remains with Universal, but the theme park rights and all surrounding developments will be controlled by Dream Chaser."**

Krishna leaned back, contemplating the implications.

Universal was playing it safe. They weren't willing to relinquish full control over the franchise's films and TV rights, as those were the real moneymakers. But Krishna didn't care about the films.

He wanted the theme park.

With this deal, he could build a real-life Jurassic Park on an island—just like in the movies. It would be a tourism powerhouse, attracting millions of visitors every year. The revenue from ticket sales, resorts, merchandise, and exclusive experiences would rival the box office profits of the films themselves.

"Interesting… very interesting."

His mind was already working on the next steps.

February 13, 2010 – The Leela Palace, Bengaluru

At the luxurious Leela Palace Hotel in Bengaluru, an important business summit was taking place. Executives from 79 major pharmaceutical companies had gathered for an exclusive conference, hosted by Oasis Pharmaceuticals.

As Varun Chaturbedi, the CEO of Oasis Pharmaceuticals, stepped out of his car, the company's marketing director, Sonu De Sozu, hurried forward to greet him with a deep bow.

"Mr. Chaturbedi, everything is prepared. The conference hall is full."

Varun gave a small nod. "Good. Let's proceed as planned."

Inside the conference room, the air was thick with anticipation. Representatives from Johnson & Johnson, Novartis, Merck, Takeda Pharmaceuticals, and other global giants sat in their designated seats, waiting for the presentation to begin.

Sonu De Sozu took the stage, adjusting the microphone. "Good morning, ladies and gentlemen. My name is Sonu De Sozu, and I am the marketing director of Oasis Pharmaceuticals. We appreciate your presence here today."

A round of polite applause followed.

Sonu continued with a knowing smile. "We at Oasis Pharmaceuticals have always been committed to innovation. Today, we are proud to introduce three groundbreaking new products."

A hushed silence filled the room.

"The first product is a pharmaceutical formula that stimulates secondary breast development in women."

A stunned murmur spread through the audience. Some executives leaned forward in their seats, their interest piqued.

"Clinical trials show that more than 90% of women experience noticeable enhancement within weeks of usage."

Gasps. Whispers.

This was a billion-dollar industry waiting to happen.

Sonu continued smoothly. "The second and third products are advanced dermatological treatments: a whitening solution and a skin repair formula capable of eliminating acne and freckles. Our clinical trials show that even individuals with darker skin tones can achieve visible whitening effects."

Behind him, the big screen lit up, displaying before-and-after comparisons from clinical trials.

A collective gasp echoed through the hall.

Executives exchanged wide-eyed glances, some immediately whispering to their assistants. The potential market for these products was staggering.

Just as the tension reached its peak, Sonu delivered the final bombshell.

"Oasis Pharmaceuticals will be auctioning off the global distribution rights for these products. Interested parties may remain after the presentation."

For a brief moment, silence.

Then—chaos.

Executives from some of the biggest pharmaceutical firms rushed to claim their interest.

"Johnson & Johnson will participate!"

"Novartis wants in!"

"Merck as well!"

"Takeda Pharmaceuticals!"

Varun Chaturbedi, watching from the back of the room, allowed himself a smirk.

Oasis Pharmaceuticals was about to shake the global pharmaceutical industry.

And this was only the beginning.